Stemline Therapeutics Announces Presentation of ELZONRIS (tagraxofusp) Preclinical Data in Systemic Sclerosis, an Autoimmune Disorder, at EULAR Congress June 17, 2019 - NASDAQ Companies 0 » View More News for June 17, 2019